Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
株式のランク #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
株価
$0.16240909
最終同期: 2025-03-04
時価総額
$35.68M
変化(1日)
0.27%
変化(1年)
0.00%
CN
取引 Dali Pharmaceuticalco.,Ltd (603963)

カテゴリー

Dali Pharmaceuticalco.,Ltd(603963)の配当履歴
Dali Pharmaceuticalco.,Ltd(証券コード:603963)は合計で3回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:$0.15
配当利回り(TTM):0
2018から2026までのDali Pharmaceuticalco.,Ltd(603963)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
2026 (TTM) $0.046 0.00%
2021 $0.046 -22.30%
2019 $0.0592 30.11%
2018 $0.0455 0.00%
すべての配当支払いの一覧
配当 変化
2026 (TTM) $0.046 0.00%
2021 $0.046 -54.05%
2019 $0.1001 0.10%
2018 $0.1 0.00%
同業他社や競合企業の配当履歴